Lung Allograft Dysfunction: Does Aspiration Hold the Key?

por Pragman, Alexa A.
Publicado 2022

634. Chlorhexidine Oral Rinses to Alter the Oral and Sputum Microbiota in COPD (CLIMB): a Randomized, Double-blinded, Placebo-controlled, Parallel-group Pilot Study

por Pragman, Alexa, Fieberg, Ann, Reilly, Cavan, Wendt, Chris
Publicado 2020

Balancing Benefits and Risks: Do Inhaled Corticosteroids Modify the Lung Microbiome?

por Singh, Shivani, Pragman, Alexa A., Segal, Leopoldo N.
Publicado 2021

Chlorhexidine oral rinses for symptomatic COPD: a randomised, blind, placebo-controlled preliminary study

por Pragman, Alexa A, Fieberg, Ann M, Reilly, Cavan S, Wendt, Christine
Publicado 2021

The Lung Microbiome in Moderate and Severe Chronic Obstructive Pulmonary Disease

por Pragman, Alexa A., Kim, Hyeun Bum, Reilly, Cavan S., Wendt, Christine, Isaacson, Richard E.
Publicado 2012

Chronic obstructive pulmonary disease upper airway microbiota alpha diversity is associated with exacerbation phenotype: a case-control observational study

por Pragman, Alexa A., Knutson, Katherine A., Gould, Trevor J., Isaacson, Richard E., Reilly, Cavan S., Wendt, Chris H.
Publicado 2019

Chronic obstructive pulmonary disease upper airway microbiome is associated with select clinical characteristics

por Pragman, Alexa A., Knutson, Katherine A., Gould, Trevor J., Hodgson, Shane W., Isaacson, Richard E., Reilly, Cavan S., Wendt, Chris H.
Publicado 2019

The lung tissue microbiota of mild and moderate chronic obstructive pulmonary disease

por Pragman, Alexa A., Lyu, Tianmeng, Baller, Joshua A., Gould, Trevor J., Kelly, Rosemary F., Reilly, Cavan S., Isaacson, Richard E., Wendt, Chris H.
Publicado 2018

The relationship between oral health and COPD exacerbations

por Baldomero, Arianne K, Siddiqui, Mariam, Lo, Chia-Yin, Petersen, Ashley, Pragman, Alexa A, Connett, John E, Kunisaki, Ken M, Wendt, Chris H
Publicado 2019